Drawing for TPM

USPTO serial 79177428

TPM

Reviewed by CopyMark Law Group

Reg. 5537605Status 708Registered
Filing date
Status date
Registration date
Aug 14, 2018
Examiner
LAM, HAI-LY HUYNH
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with TPM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, N.W.10th FloorWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for treating skin conditions [ , itchiness, pruritus, deterioration of acne, bacteria trapped in skin pores and hair follicles, hives, blisters, rosacea, blemishes, skin homeostasis, inflammation, erythema, wounds, burns, sun sensitivity, photosensitivity, dandruff, dermatitis, seborrheic dermatitis, gingivitis, rashes, boils, shingles, dry, cracked, scaly or rough skin, open sores, lesions, sunburn, heat burn, psoriasis, insect bites, calluses, corns, eczema, photo-aging, cellulite, wrinkles, scars, stretch marks, common warts, plantar warts, thickening of the epidermal layer, pigmentation and mastitis ] ; [ anti-aging pharmaceuticals; carriers for pharmaceutical preparations in the form of tablets, dissolvable tablets, effervescent tablets, chewable tablets, capsules and caplets, suppositories, enema preparations, liquid suspensions, semi-solid pastes, drops, solutions, suspensions, creams, ointments, lotions, pastes, gels, powders, granules, aerosols, transdermal patches, dressings, vesicles, liposomes, microspheres, lyophilisations, injections, sprays, balms, liniments, oils, infusions, lozenges, drenches, implants, bolus and pellets all for facilitating the delivery of pharmaceutical preparations; pharmaceutical moisturizing preparations, namely, medicated moisturizers; oils adapted for pharmaceutical purposes, namely, medicinal oils; ] pharmaceutical preparations containing vitamins for treating skin conditions [ , itchiness, pruritus, deterioration of acne, bacteria trapped in skin pores and hair follicles, hives, blisters, rosacea, blemishes, skin homeostasis, inflammation, erythema, wounds, burns, sun sensitivity, photosensitivity, dandruff, dermatitis, seborrheic dermatitis, gingivitis, rashes, boils, shingles, dry, cracked, scaly or rough skin, open sores, lesions, sunburn, heat burn, psoriasis, insect bites, calluses, corns, eczema, photo-aging, cellulite, wrinkles, scars, stretch marks, common warts, plantar warts, thickening of the epidermal layer, pigmentation and mastitis; anti-aging pharmaceuticals containing vitamins ] ; pharmaceutical preparations for human use for treating skin conditions [ , itchiness, pruritus, deterioration of acne, bacteria trapped in skin pores and hair follicles, hives, blisters, rosacea, blemishes, skin homeostasis, inflammation, erythema, wounds, burns, sun sensitivity, photosensitivity, dandruff, dermatitis, seborrheic dermatitis, gingivitis, rashes, boils, shingles, dry, cracked, scaly or rough skin, open sores, lesions, sunburn, heat burn, psoriasis, insect bites, calluses, corns, eczema, photo-aging, cellulite, wrinkles, scars, stretch marks, common warts, plantar warts, thickening of the epidermal layer, pigmentation and mastitis ] ; [ anti-aging pharmaceuticals for human use; veterinary preparations for treating skin conditions, itchiness, pruritus, deterioration of acne, bacteria trapped in skin pores and hair follicles, hives, blisters, rosacea, blemishes, skin homeostasis, inflammation, erythema, wounds, burns, sun sensitivity, photosensitivity, dandruff, dermatitis, seborrheic dermatitis, gingivitis, rashes, boils, shingles, dry, cracked, scaly or rough skin, open sores, lesions, sunburn, heat burn, psoriasis, insect bites, calluses, corns, eczema, photo-aging, cellulite, wrinkles, scars, stretch marks, common warts, plantar warts, thickening of the epidermal layer, pigmentation, mastitis, enhancing performance, boosting immunity and improving fertility; anti-aging veterinary preparations; health food supplements made principally of vitamins; dietetic food and substances adapted for medical or veterinary use, namely, dietary supplements; ] dietetic food and substances adapted for medical or veterinary use, namely, medicated and non-medicated nutritional [ , dietary, health food, protein, vitamin, mineral including mineral salts, and dietary trace element supplements ] ; dietetic food and substances adapted for medical or veterinary use, namely, medicated additives for animal foodstuffs for use as nutritional supplements; [ mineral additives for animal foodstuffs for use as nutritional supplements; dietetic food and substances adapted for medical or veterinary use, namely, salt blocks, cakes, nutritional supplement bars, cookies and biscuits; ] medicated food additives for use as nutritional supplements for animals and medicated food supplements for animal foodstuffs; medicated nutritional additives for animal food for use as nutritional supplements [ ; medicated animal feed; mineral salts for animals for medical purposes; nutritional additives to animal feed for use as nutritional supplements; nutritional animal feed supplements; nutritional supplements for animals; protein supplements for animals and for use as additives to animal foodstuffs for use as nutritional supplements ]ACTIVE—
031[ Food for animals ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Oct 10, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Oct 9, 2026XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 9, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 5, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 24, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 9, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 9, 2025C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 9, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 9, 2025C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 2, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 10, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Aug 14, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 2, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 29, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 29, 2018FIMPFINAL DISPOSITION PROCESSED—
Nov 14, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 24, 2018GPNXNOTIFICATION PROCESSED BY IB—
Aug 14, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 23, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 5, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 5, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 5, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 5, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 5, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 5, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 5, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 14, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 13, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 9, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 9, 2018ALIEASSIGNED TO LIE—
Aug 3, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 20, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 3, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 3, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 5, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 5, 2017ALIEASSIGNED TO LIE—
Aug 11, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 28, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 28, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Jun 28, 2016CNSLSUSPENSION LETTER WRITTEN—
Jun 8, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 31, 2015RFNTREFUSAL PROCESSED BY IB—
Dec 9, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 9, 2015RFRRREFUSAL PROCESSED BY MPU—
Dec 8, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 8, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2015DOCKASSIGNED TO EXAMINER—
Dec 4, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 3, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance